FI945654A - Salter av desferrioxamin-B samt deras användning som oralt effektiva järnkelatorer - Google Patents
Salter av desferrioxamin-B samt deras användning som oralt effektiva järnkelatorer Download PDFInfo
- Publication number
- FI945654A FI945654A FI945654A FI945654A FI945654A FI 945654 A FI945654 A FI 945654A FI 945654 A FI945654 A FI 945654A FI 945654 A FI945654 A FI 945654A FI 945654 A FI945654 A FI 945654A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- desferrioxamine
- salts
- orally active
- iron chelators
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title 2
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical class CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 title 1
- 239000002738 chelating agent Substances 0.000 title 1
- 229910052742 iron Inorganic materials 0.000 title 1
- 229910006069 SO3H Inorganic materials 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929211779A GB9211779D0 (en) | 1992-06-03 | 1992-06-03 | Amine salts |
| PCT/GB1993/000940 WO1993024451A1 (en) | 1992-06-03 | 1993-05-06 | Desferrioxamine-b salts and their use as orally effective iron chelators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI945654A true FI945654A (sv) | 1994-11-30 |
| FI945654A0 FI945654A0 (sv) | 1994-11-30 |
Family
ID=10716488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI945654A FI945654A0 (sv) | 1992-06-03 | 1994-11-30 | Salter av desferrioxamin-B samt deras användning som oralt effektiva järnkelatorer |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5739167A (sv) |
| EP (1) | EP0643690B1 (sv) |
| JP (1) | JPH07507288A (sv) |
| KR (1) | KR950701907A (sv) |
| AT (1) | ATE166342T1 (sv) |
| AU (1) | AU672607B2 (sv) |
| CA (1) | CA2135394A1 (sv) |
| DE (1) | DE69318711T2 (sv) |
| DK (1) | DK0643690T3 (sv) |
| ES (1) | ES2117132T3 (sv) |
| FI (1) | FI945654A0 (sv) |
| GB (1) | GB9211779D0 (sv) |
| HK (1) | HK1009330A1 (sv) |
| NO (1) | NO302749B1 (sv) |
| NZ (1) | NZ252738A (sv) |
| TW (1) | TW230203B (sv) |
| WO (1) | WO1993024451A1 (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR009655A1 (es) * | 1996-12-10 | 2000-04-26 | Novartis Ag | Una composicion parenteralmente inyectable, un metodo para su preparacion, metodos para el tratamiento de enfermedades, una modificacion decristal de 1-decansulfonato de desferrioxamina, su uso, un proceso para la produccion de dicha modificacion de cristal y una preparacion farmaceutica que |
| US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
| GB9727224D0 (en) * | 1997-12-23 | 1998-02-25 | Nycomed Imaging As | Method |
| US6323218B1 (en) | 1998-03-11 | 2001-11-27 | The General Hospital Corporation | Agents for use in the treatment of Alzheimer's disease |
| US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
| GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
| US6958161B2 (en) * | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| US8236783B2 (en) * | 2006-08-15 | 2012-08-07 | Duke University | ROS-sensitive iron chelators and methods of using the same |
| US9139456B2 (en) | 2008-04-16 | 2015-09-22 | The Curators Of The University Of Missouri | Chelating compounds and immobilized tethered chelators |
| US7932326B2 (en) * | 2008-04-16 | 2011-04-26 | The University Of Kentucky Research Foundation | Chelating compounds and immobilized tethered chelators |
| US9259670B2 (en) | 2008-04-16 | 2016-02-16 | The University Of Kentucky Research Foundation | Flow-through filter to remove aluminum from medical solutions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH438351A (de) * | 1959-09-25 | 1967-06-30 | Ciba Geigy | Verfahren zur Herstellung neuer Wuchsstoffe |
| FR1898M (fr) * | 1961-04-07 | 1963-07-08 | Ciba Geigy | Nouvelle substance utilisable en thérapeutique. |
| US3679660A (en) * | 1969-06-09 | 1972-07-25 | Agatha C Magnus | Glucosamine-alkylsulfonate and process |
| US3652411A (en) * | 1969-12-04 | 1972-03-28 | Mobil Oil Corp | Polyglycol base lubricant |
| US4419365A (en) * | 1981-12-21 | 1983-12-06 | Ciba-Geigy Corporation | Method of treating Alzheimer's disease |
| US4684482A (en) * | 1984-01-26 | 1987-08-04 | Oral-D (L.P.) | Orally effective ion chelators |
| IT1173992B (it) * | 1984-05-16 | 1987-06-24 | Bioresearch Spa | Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale |
| MX12394A (es) * | 1987-07-23 | 1993-12-01 | Ciba Geigy Ag | Procedimiento par la obtencion de carbamatos de polietilenglicol. |
| AU1996192A (en) * | 1991-05-13 | 1992-12-30 | Oral-D | Substituted orally effective ion chelators related to deferoxamine |
-
1992
- 1992-06-03 GB GB929211779A patent/GB9211779D0/en active Pending
-
1993
- 1993-04-22 TW TW082103080A patent/TW230203B/zh active
- 1993-05-06 CA CA002135394A patent/CA2135394A1/en not_active Abandoned
- 1993-05-06 EP EP93911928A patent/EP0643690B1/en not_active Expired - Lifetime
- 1993-05-06 NZ NZ252738A patent/NZ252738A/en unknown
- 1993-05-06 ES ES93911928T patent/ES2117132T3/es not_active Expired - Lifetime
- 1993-05-06 JP JP6500277A patent/JPH07507288A/ja active Pending
- 1993-05-06 DK DK93911928T patent/DK0643690T3/da active
- 1993-05-06 AT AT93911928T patent/ATE166342T1/de not_active IP Right Cessation
- 1993-05-06 WO PCT/GB1993/000940 patent/WO1993024451A1/en active IP Right Grant
- 1993-05-06 US US08/343,599 patent/US5739167A/en not_active Expired - Lifetime
- 1993-05-06 AU AU42700/93A patent/AU672607B2/en not_active Ceased
- 1993-05-06 KR KR1019940704389A patent/KR950701907A/ko not_active Application Discontinuation
- 1993-05-06 DE DE69318711T patent/DE69318711T2/de not_active Expired - Lifetime
-
1994
- 1994-11-30 FI FI945654A patent/FI945654A0/sv unknown
- 1994-12-01 NO NO944617A patent/NO302749B1/no not_active IP Right Cessation
-
1996
- 1996-03-11 US US08/613,562 patent/US5663201A/en not_active Expired - Lifetime
-
1998
- 1998-08-18 HK HK98109975A patent/HK1009330A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW230203B (sv) | 1994-09-11 |
| NO302749B1 (no) | 1998-04-20 |
| EP0643690B1 (en) | 1998-05-20 |
| ATE166342T1 (de) | 1998-06-15 |
| NO944617D0 (no) | 1994-12-01 |
| DK0643690T3 (da) | 1999-01-25 |
| DE69318711D1 (de) | 1998-06-25 |
| KR950701907A (ko) | 1995-05-17 |
| AU672607B2 (en) | 1996-10-10 |
| JPH07507288A (ja) | 1995-08-10 |
| GB9211779D0 (en) | 1992-07-15 |
| EP0643690A1 (en) | 1995-03-22 |
| DE69318711T2 (de) | 1998-11-19 |
| NZ252738A (en) | 1996-08-27 |
| HK1009330A1 (en) | 1999-05-28 |
| US5663201A (en) | 1997-09-02 |
| FI945654A0 (sv) | 1994-11-30 |
| WO1993024451A1 (en) | 1993-12-09 |
| AU4270093A (en) | 1993-12-30 |
| ES2117132T3 (es) | 1998-08-01 |
| CA2135394A1 (en) | 1993-12-09 |
| NO944617L (no) | 1995-01-05 |
| US5739167A (en) | 1998-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT88060A (pt) | Processo para a preparacao de polietilenoglicol-carbaminatos | |
| DE69408666D1 (de) | Risperidon pamoate | |
| CA2011294A1 (en) | Carbonylation catalyst system | |
| FI945654A (sv) | Salter av desferrioxamin-B samt deras användning som oralt effektiva järnkelatorer | |
| DE69332259D1 (de) | Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung | |
| ES8607218A1 (es) | Un procedimiento para preparar compuestos de amidina | |
| EP0228845A3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
| MY103393A (en) | 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
| MX9804828A (es) | Benzotiazolona etanaminas biologicamente activas. | |
| MY103910A (en) | 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
| ATE173471T1 (de) | Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel | |
| BR9406996A (pt) | Enanciômero processo para preparar o mesmo processo para ciclizar um composto e composto intermediário | |
| ZA929175B (en) | 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes. | |
| ES553600A0 (es) | Un procedimiento para la preparacion de nuevos derivados de diamina. | |
| ATE77744T1 (de) | Verwendung von pyrrothinderivaten. | |
| NO954410L (no) | Fremgangsmåte og fremstilling av NG-monoalkyl-L-arginin og beslektede forbindelser | |
| ES8703421A1 (es) | Procedimiento para preparar derivados de pirrolidindiona. | |
| NO932251L (no) | Chelaterende forbindelser | |
| SE8303718D0 (sv) | E-homo-eburnane derivatives and a process for preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |